Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

OxThera Announces Completion of Recruitment in Phase 3 ePHex Study With Oxabact® in Patients With Primary Hyperoxaluria

Monday, April 06, 2020

OxThera AB a privatelyheld biopharmaceutical company dedicated to improving the lives of people with Primary Hyperoxaluria PH announced today that it has completed enrollment in its Oxabact ePHex phase III study

IVERIC bio Announces Fast Track Designation from U.S. FDA for Zimura® for the Treatment of Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration

Saturday, April 04, 2020

IVERIC bio Inc announced that the US Food and Drug Administration FDA has granted Fast Track designation to Zimura avacincaptad pegol a novel complement C inhibitor in development for the treatment of geographic atrophy GA secondary to dry agerelated...

New COVID-19 at-home test with social distancing ready for validation study

Friday, April 03, 2020

Care Access Research the leader in rapid development and management of highperforming clinical research sites announced it is leading a validation trial in conjunction with the FDA for a new athome COVID test developed by a private genomics lab that...

Digital Science partners with Zhipu.AI to conduct data challenges and build COVID-19 information portal

Friday, April 03, 2020

Digital Science a leading technology company serving emergent needs across the research sector is pleased to announce a partnership with Beijingbased technology company ZhipuAI to conduct data challenges and collaborate in building a COVID informatio...

SAB Biotherapeutics Awarded $27M Contract to Develop Novel Rapid Response Capability for U.S. Department of Defense

Friday, April 03, 2020

SAB Biotherapeutics SAB a clinicalstage biopharmaceutical company advancing a new class of immunotherapies leveraging the native human immune response announced today it has been awarded a contract from the US Department of Defense DoD to develop and...

RedHill Biopharma Completes Acquisition of Movantik® from AstraZeneca

Friday, April 03, 2020

RedHill Biopharma Ltd a specialty biopharmaceutical company focused on gastrointestinal diseases today announced that it has completed the recently announced acquisition of the global rights excluding Europe Canada and Israel to Movantik naloxegol fo...

Concert Pharmaceuticals Announces Plans for CTP-543 Phase 3 Trials in Alopecia Areata

Thursday, April 02, 2020

Concert Pharmaceuticals Inc announced the details of its pivotal Phase trials of CTP in patients with moderatetosevere alopecia areata an autoimmune disorder that results in patchy or complete hair loss Concert discussed key aspects of its planned P...

GE Announces Completion of BioPharma Sale to Danaher, Receives $20 Billion Net Cash Proceeds

Thursday, April 02, 2020

GE announced the completion of the sale of its BioPharma business to Danaher Corporation for approximately billion of net proceeds

Eisai and Seikagaku Enter into Agreement for the Co-development and Marketing Alliance of SI-613, a Treatment of Osteoarthritis, in China

Wednesday, April 01, 2020

Eisai Co Ltd and Seikagaku announced today that the companies have entered into an agreement for the codevelopment and marketing alliance in China for SI diclofenac conjugated sodium hyaluronate a therapeutic agent for osteoarthritis discovered by Se...

Phio Announces Positive New Data Validating the INTASYL™ Immunotherapy Platform's Ability to Develop Novel Compounds Capable of Inhibiting Cancer Tumor Growth

Wednesday, April 01, 2020

Phio Pharmaceuticals Corp a biotechnology company developing the next generation of immunooncology therapeutics based on its proprietary selfdelivering RNAi INTASYL therapeutic platform today announced data from various animal studies validating the...

MECO - 90 Years